Stockreport

Capricor Therapeutics To Present One-Year Efficacy Results From Its Ongoing HOPE-2 Open Label Extension Study At 2022 Parent Project Muscular Dystrophy Annual Conference [TheStreet.com]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, today announced that the Company will present one [Read more]